Suitable Classification Consortium for Esophageal Squamous Cell Carcinoma Subtype Ad hoc research -Integrated analysis of previous research and SUCCESS study

Suitable Classification Consortium for Esophageal Squamous Cell Carcinoma Subtype Ad hoc research -Integrated Analysis of previous research and SUCCESS study - SUCCESS Study Ad hoc research - Integrated Analysis of previous research and SUCCESS study

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000043637

Enrollment

375

Registered

2021-03-16

Start date

2020-01-08

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Esophageal Cancer

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients who participated in the previous study ([Expression profiling of clinical stage II/III esophageal squamous cell carcinoma patients treated with definitive chemoradiotherapy: National Cancer Center Japan IRB 16-97, UMIN-C000000459], and [long-term prognosis of its study: National Cancer Center Japan IRB 19-14]), and SUCCESS Study (Suitable Classification Consortium for Esophageal Squamous Cell Carcinoma Subtype: UMIN000016141)

Exclusion criteria

Exclusion criteria: Patients who disagree with the use of clinical data in this study

Design outcomes

Primary

Measure	Time frame
To evaluate the relationship between the therapeutic effect/prognosis and the subtype classification using the RNA expression pattern of esophageal cancer specimen	—

Countries

Japan

Contacts

Public ContactShinya Ohashi

Kyoto University Hospital Preemptive Medicine and Lifestyle Disease Research Center

ohashish@kuhp.kyoto-u.ac.jp075-754-0073

Outcome results